Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q3 2022
Institutional positions in Evotec SE as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q2 2022
- Shares held
- 4.94M
- +165.5K (+3.5%) vs. Q2 2022
- Total value
- $43.5M
- −$13.8M (−24.1%) vs. Q2 2022
- New holders
- 3
- 8 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artisan Partners Limited Partnership | 2,287,892 | $20.1M | 0.04% | −5,392−0.2% | Reduced |
| Artal Group S.A. | 1,149,425 | $10.1M | 0.53% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 750,000 | $6.59M | 0.02% | +385,888+106.0% | Added |
| Millennium Management LLC | 366,479 | $3.22M | 0.00% | −5,519−1.5% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 222,771 | $1.96M | 0.01% | −16,198−6.8% | Reduced |
| Jane Street Group, LLC | 64,265 | $565.0K | 0.00% | −42,060−39.6% | Reduced |
| Morgan Stanley | 44,876 | $395.0K | 0.00% | +2,695+6.4% | Added |
| Renaissance Technologies LLC | 13,699 | $120.0K | 0.00% | +13,699 | New |
| Geode Capital Management, LLC | 13,238 | $116.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11,867 | $105.0K | 0.00% | −780−6.2% | Reduced |
| BlackRock Inc. | 10,558 | $93.0K | 0.00% | +732+7.4% | Added |
| UBS Group AG | 2,886 | $26.0K | 0.00% | +2,586+862.0% | Added |
| Quadrant Capital Group LLC | 1,682 | $15.0K | 0.00% | +224+15.4% | Added |
| Royal Bank of Canada | 1,584 | $14.0K | 0.00% | +1,084+216.8% | Added |
| Tower Research Capital LLC (TRC) | 1,152 | $10.0K | 0.00% | +1,152 | New |
| Signaturefd, LLC | 460 | $4.00K | 0.00% | −1,698−78.7% | Reduced |
| Washington Trust Co | 421 | $4.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 392 | $3.00K | 0.00% | +76+24.1% | Added |
| Parallel Advisors, LLC | 216 | $2.00K | 0.00% | +122+129.8% | Added |
| Wipfli Financial Advisors LLC, | 158 | $1.00K | 0.00% | +158 | New |
| Lindbrook Capital, LLC | 52 | $0 | 0.00% | −568−91.6% | Reduced |
| Bell Investment Advisors, Inc | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −165,234−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |